Intel's Q4 beats estimates, but analysts remain cautious on challenges ahead
Intel's (NASDAQ:INTC) fourth quarter results beat estimates, but analysts had mixed reactions overall. Jefferies kept ...
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels ...